When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Tracon Pharmaceuticals shares are up ~400% since the beginning of September 2020, owing to excitement surrounding its lead asset, subcutaneously administrated envafolimab.
This recent runup still places the stock down ~90% from its 2014 IPO price.
With somewhat de-risked data from envafolimab’s pivotal soft tissue sarcoma trial due mid-2021, a low bar for approval, and recent beneficial owner buying, Tracon merited a deeper dive.